Moxalactam (lamoxactam)
Hofstetter, A.
Der Urologe. Ausg. a 21(4): 239-240
1982
ISSN/ISBN: 0340-2592 PMID: 6215756 Document Number: 194772
Document emailed within 1 workday
Related Documents
Hautmann, R.; Pranada, F.; Ahlert, G. 1983: Clinical experience in the treatment of complicated urinary tract infection with different doses of moxalactam (lamoxactam) International Journal of Clinical Pharmacology Therapy and Toxicology 21(4): 209-212Pulverer, G.; Peters, G. 1982: Efficacy of the new cephalosporin antibiotics cefotaxime, cefoperazone and lamoxactam Die Medizinische Welt 33(17): 642-644
Cuena Boy, R.; Azanza Perea, J.R.; Honorato Pérez, J. 1983: Moxalactam Revista de Medicina de la Universidad de Navarra 27(1): 45-46
Herbert, D.A. 1982: Claims for moxalactam Annals of Internal Medicine 97(5): 787-788
Reed, M.D.; Bertino, J.S.; Aronoff, S.C.; Speck, W.T.; Blumer, J.L. 1982: Evaluation of moxalactam Clinical Pharmacy 1(2): 124-134
Chabbert, Y.A. 1983: Moxalactam: preclinical evaluation La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(26): 1943-1946
Casto, D.T.; Gal, P.; McCue, J.D.; Zumwalt, A.A. 1985: Salivary penetration of moxalactam Clinical Pharmacy 4(1): 67-70
Kelentey, B.A.; Kelentey, B.J. 1987: Secretion of cefsulodin and moxalactam in the saliva Fogorvosi Szemle 80(6): 183-185
Fourtillan, J.B. 1983: Moxalactam: a new group of beta-lactams La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(26): 1947-1948
Soback, S. 1989: Pharmacokinetics of single-dose administration of moxalactam in unweaned calves American Journal of Veterinary Research 50(4): 498-501
Baumgärtner, M.; Dickgiesser, N.; Müller, S.; Wundt, W. 1981: Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins Arzneimittel-Forschung 31(10): 1677-1681
Polk, R.; Hume, A.; Kline, B.J.; Cardea, J. 1983: Penetration of moxalactam and cefazolin into bone following simultaneous bolus or infusion Clinical Orthopaedics and Related Research 177: 216-221
Pajchel, G.; Borowiecka, B.; Chojnowski, W. 1992: Determination of moxalactam, aztreonam and imipenem by the perchloric hydroxylamine method Acta Poloniae Pharmaceutica 49(1-2): 7-10
Stutman, H.R.; Parker, K.M.; Marks, M.I. 1985: Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonates Pediatrics 75(2): 294-298
Andrassy, K.; Koderisch, J.; Fritz, S.; Ritz, E. 1983: New beta-lactam antibiotics and hemorrhagic diathesis: comparison of moxalactam and cefotaxime Clinical Therapeutics 6(1): 34-42
Nasnas, R.; Gutmann, L.; Kitzis, M.D.; Goldstein, F.; Acar, J.F. 1982: Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains Pathologie-Biologie 30(6): 341-344
Duval, J.; Deforges, L.; Bergogne-Berezin, E.; Chabbert, Y.A.; Courtieu, A.L.; Cluzel, R.; Dabernat, H.; Witchitz, J.L. 1983: In vitro action of moxalactam on hospital bacteria. Results of a multicenter survey La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(26): 1949-1952
Crots, L.D.; Obeid, F.N.; Horst, H.M.; Bivins, B.A. 1985: Twice-daily moxalactam versus gentamicin and clindamycin in patients with penetrating abdominal trauma Clinical Pharmacy 4(3): 316-320
Gómez-Acebo, F.; Palenque, E.; Scarpellini Vera, A.; Rodríguez Otero, J.J.; Fernández Epifanio, J.L. 1983: Haemophilus influenzae type b meningitis resistant to ampicillin and chloramphenicol treated with moxalactam Anales Espanoles de Pediatria 18(5): 410-411
Brown, R.B.; Klar, J.; Lemeshow, S.; Teres, D.; Pastides, H.; Sands, M. 1986: Enhanced bleeding with cefoxitin or moxalactam. Statistical analysis within a defined population of 1493 patients Archives of Internal Medicine 146(11): 2159-2164